Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
A peptide derived from G0/G1 switch gene 2 acts as noncompetitive inhibitor of adipose triglyceride lipase
It has been used to treat conditions such as inflammatory bowel disease (IBD), ulcers, and leaky gut syndrome by promoting mucosal healing and reducing inflammation within the gut (Jain et al., 2021)
Experience chronic fatigue, mood issues, or low motivation during weight loss efforts
Neuron 105 , 276292.e5 (2020)
Subcutaneous vs Intramuscular Injection There are two injection routes used in practice: Subcutaneous (SubQ) the standard approach Reconstitute BPC-157 in bacteriostatic water as directed by your provider Inject under the skin in the abdomen, away from scar tissue Rotate injection sites to prevent localised irritation BPC-157 is water-stable and does not require acetate buffers practical for daily use Intramuscular (IM) for localised muscle injury Used when targeting a specific muscle group directly Less common in research protocols
It is not approved by the FDA for fat loss or any other use, and any clinical application falls under the supervision of a licensed medical provider
US$ 21.23
US$ 27.32
US$ 20.02
US$ 25.42
US$ 29.60
US$ 26.28
US$ 24.04
